A Randomized, Double-Blind, Placebo-Controlled Trial of a Selective COX-2 Inhibitor, GW406381, in Patients With Postherpetic Neuralgia

This publication has 21 references indexed in Scilit:

• The tetrapartite synapse: Path to CNS sensitization and chronic pain
  Pain, 2006
• Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course study
  BMC Neurology, 2006
• The Cyclooxygenase-2 Inhibitor GW406381X [2-(4-Ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] Is Effective in Animal Models of Neuropathic Pain and Central Sensitization
  The Journal of Pharmacology and Experimental Therapeutics, 2005
• Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors
  Bioorganic & Medicinal Chemistry Letters, 2004
• A Retrospective Review of the Effect of COX-2 Inhibitors on Blood Pressure Change
  Clinical Journal of Sport Medicine, 2003
• Pregabalin for the treatment of postherpetic neuralgia
  Neurology, 2003
• The intraspinal release of prostaglandin E2 in a model of acute arthritis is accompanied by an up-regulation of cyclo-oxygenase-2 in the spinal cord
  Neuroscience, 1999
• The management of postherpetic neuralgia
  Published by Oxford University Press (OUP) ,1997
• Pain and its persistence in herpes zoster
  Pain, 1996
• Secondary prevention of vascular disease by prolonged antiplatelet treatment
  BMJ, 1988